Showing results (11-20 of 444) with videos related to
Sort By:
Pageof 45
Expert Opinion on Pharmacotherapy|March 31, 2016
Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutationsLavinia Spain, Maximilian Julve, James LarkinCancer Treatment Reviews|February 15, 2016
Management of toxicities of immune checkpoint inhibitorsLavinia Spain, Stefan Diem, James LarkinExpert Opinion on Investigational Drugs|May 7, 2013
Phase I/II RAF kinase inhibitors in cancer therapySamra Turajlic, Zohra Ali, Nadia Yousaf, et al.Current Opinion in Urology|July 1, 2015
How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma?Aspasia Soultati, Mark Stares, Charles Swanton, et al.Melanoma Management|September 8, 2018
Pembrolizumab in the management of metastatic melanomaLavinia Spain, Eugenie Younger, Emine Hatipoglu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2020
Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-center Retrospective AnalysisFrancesca Comito, Isla Leslie, Laura Boos, et al.Cancer Cell|February 5, 2022
Metastasis and organotropism: A look through the lens of large-scale clinical sequencing dataAlexander Coulton, Samra TurajlicScience (New York, N.Y.)|April 29, 2016
Metastasis as an evolutionary processSamra Turajlic, Charles SwantonESMO Open|March 14, 2018
Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanomaKok Haw Jonathan Lim, Lavinia Spain, Claire Barker, et al.ESMO Open|July 10, 2020
Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanomaDavid M Favara, Lavinia Spain, Lewis Au, et al.Pageof 45